Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
15 Sep 2015

Considerations when selecting a genomic test to use in specific breast cancer patients

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hope S. Rugo, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center…
EMJ
9 Sep 2015

Genomic profiling for defining luminal subtypes

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…
EMJ
9 Sep 2015

Using genomic testing to access the suitability of breast cancer patients for chemotherapy

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses the…
EMJ
26 Aug 2015

Registry evaluating the impact of genomic testing on treatment of prostate cancer patients

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…
EMJ
26 Aug 2015

CancerLinQ: ASCO’s initiative to improve patient care through big data

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE…
EMJ
26 Aug 2015

ARAMIS trial of ODM-201 for high-risk non-metastatic castration-resistant prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…
EMJ
26 Aug 2015

Immune checkpoint inhibitors and biomarker-driven strategies for managing lung cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen…
EMJ
26 Aug 2015

An update on the treatment of chronic lymphocytic leukaemia

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing…
We’ve noticed you’re accessing
from North/South America.